Skip to main content
. 2016 Nov 8;8(48):83446–83456. doi: 10.18632/oncotarget.13225

Figure 4. Detection of tumor DNA in circulating DNA and prognostic significance in pancreatic cancer patients.

Figure 4

A. The maximum mutant allele fraction in cfDNA or ctcDNA trended higher in patients with extensive disease, although this was not statistically significant. B. Overall survival trended lower in patients with detectable tumor DNA in cfDNA (ctDNA+, n = 24) than in those with no detectable tumor DNA (ctDNA-, n = 10), with a total of 11 and 1 deaths, respectively.